HEADER IMMUNE SYSTEM 26-AUG-05 2ATY TITLE COMPLEMENT RECEPTOR CHIMAERIC CONJUGATE CR2-IG COMPND MOL_ID: 1; COMPND 2 MOLECULE: COMPLEMENT RECEPTOR CHIMERIC CONJUGATE CR2-IG; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: CHIMERIC PROTEIN CONSISTING OF PORTIONS OF A COMPND 6 COMPLEMENT COMPONENT CR2 FROM HUMAN, A LINKER REGION, AND A PORTION COMPND 7 OF IMMUNOGLOBULIN GAMMA CHAIN FROM MOUSE. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HUMAN, MOUSE; SOURCE 4 ORGANISM_TAXID: 9606, 10090; SOURCE 5 GENE: CR2, C3DR, IGHG1, IGH-4; SOURCE 6 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: MOUSE; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: NS/0 KEYWDS IMMUNOGLOBULIN FOLD, ANTIBODY, COMPLEMENT, IMMUNE SYSTEM EXPDTA SOLUTION SCATTERING MDLTYP CA ATOMS ONLY, CHAIN A, B AUTHOR H.E.GILBERT,M.ASLAM,J.M.GUTHRIDGE,V.M.HOLERS,S.J.PERKINS REVDAT 9 14-FEB-24 2ATY 1 REMARK REVDAT 8 13-JUN-18 2ATY 1 REMARK REVDAT 7 11-OCT-17 2ATY 1 REMARK REVDAT 6 21-JUN-17 2ATY 1 DBREF SEQADV REVDAT 5 14-JUL-10 2ATY 1 SOURCE REVDAT 4 07-APR-10 2ATY 1 REMARK REVDAT 3 24-FEB-09 2ATY 1 VERSN REVDAT 2 07-FEB-06 2ATY 1 JRNL REVDAT 1 31-JAN-06 2ATY 0 JRNL AUTH H.E.GILBERT,M.ASLAM,J.M.GUTHRIDGE,V.M.HOLERS,S.J.PERKINS JRNL TITL EXTENDED FLEXIBLE LINKER STRUCTURES IN THE COMPLEMENT JRNL TITL 2 CHIMAERIC CONJUGATE CR2-IG BY SCATTERING, ANALYTICAL JRNL TITL 3 ULTRACENTRIFUGATION AND CONSTRAINED MODELLING: IMPLICATIONS JRNL TITL 4 FOR FUNCTION AND THERAPY. JRNL REF J.MOL.BIOL. V. 356 397 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16375923 JRNL DOI 10.1016/J.JMB.2005.11.050 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : INSIGHTII 98 REMARK 3 AUTHORS : REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 752 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ATY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-SEP-05. REMARK 100 THE DEPOSITION ID IS D_1000034307. REMARK 265 REMARK 265 EXPERIMENTAL DETAILS REMARK 265 REMARK 265 EXPERIMENT TYPE : SMALL ANGLE X-RAY SCATTERING REMARK 265 DATA ACQUISITION REMARK 265 RADIATION/NEUTRON SOURCE : SRS DARESBURY REMARK 265 SYNCHROTRON (Y/N) : Y REMARK 265 BEAMLINE TYPE : 2.1 REMARK 265 BEAMLINE INSTRUMENT : NULL REMARK 265 DETECTOR TYPE : QUADRANT DETECTOR REMARK 265 DETECTOR MANUFACTURER DETAILS : NULL REMARK 265 TEMPERATURE (KELVIN) : 288 REMARK 265 PH : 7.4 REMARK 265 NUMBER OF TIME FRAMES USED : 1 REMARK 265 PROTEIN CONCENTRATION RANGE (MG/ML) : 0.2-0.4 REMARK 265 SAMPLE BUFFER : 10 MM NA PHOSPHATE REMARK 265 137 MM NACL REMARK 265 DATA REDUCTION SOFTWARE : OTOKO REMARK 265 GUINIER MEAN RADIUS OF GYRATION (NM) : 5.39 REMARK 265 SIGMA MEAN RADIUS OF GYRATION : 0.14 REMARK 265 R(XS-1) MEAN CROSS SECTIONAL RADII (NM) : 2.18 REMARK 265 R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.07 REMARK 265 R(XS-2) MEAN CROSS SECTIONAL RADII (NM) : NULL REMARK 265 R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : NULL REMARK 265 P(R) PROTEIN LENGTH (NM) : 1 REMARK 265 REMARK 265 EXPERIMENT TYPE : SMALL ANGLE NEUTRON SCATTERING REMARK 265 DATA ACQUISITION REMARK 265 RADIATION/NEUTRON SOURCE : ISIS RUTHERFORD REMARK 265 SYNCHROTRON (Y/N) : Y REMARK 265 BEAMLINE TYPE : LOQ REMARK 265 BEAMLINE INSTRUMENT : NULL REMARK 265 DETECTOR TYPE : HE-3 ORDELA DETECTOR REMARK 265 DETECTOR MANUFACTURER DETAILS : NULL REMARK 265 TEMPERATURE (KELVIN) : 288 REMARK 265 PH : 7.4 REMARK 265 NUMBER OF TIME FRAMES USED : 1 REMARK 265 PROTEIN CONCENTRATION RANGE (MG/ML) : 0.2-0.4 REMARK 265 SAMPLE BUFFER : 10 MM NA PHOSPHATE REMARK 265 137 MM NACL 99.9% D2O REMARK 265 DATA REDUCTION SOFTWARE : COLETTE REMARK 265 GUINIER MEAN RADIUS OF GYRATION (NM) : 5.29 REMARK 265 SIGMA MEAN RADIUS OF GYRATION : 0.01 REMARK 265 R(XS-1) MEAN CROSS SECTIONAL RADII (NM) : 1.93 REMARK 265 R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.12 REMARK 265 R(XS-2) MEAN CROSS SECTIONAL RADII (NM) : NULL REMARK 265 R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : NULL REMARK 265 P(R) PROTEIN LENGTH (NM) : 1 REMARK 265 REMARK 265 DATA ANALYSIS AND MODEL FITTING: REMARK 265 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 265 SOFTWARE USED : INSIGHT II, SCTPL7, GNOM REMARK 265 SOFTWARE AUTHORS : NULL REMARK 265 STARTING MODEL : NULL REMARK 265 REMARK 265 CONFORMERS, NUMBER CALCULATED : NULL REMARK 265 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 265 CONFORMERS, SELECTION CRITERIA : NULL REMARK 265 REMARK 265 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 265 REMARK 265 OTHER DETAILS: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IGY RELATED DB: PDB REMARK 900 STRUCTURE OF INTACT ANTIBODY IGG1 REMARK 900 RELATED ID: 1GHQ RELATED DB: PDB REMARK 900 CR2-C3D COMPLEX STRUCTURE REMARK 900 RELATED ID: 1W2R RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF FREE CR2 SCR 1-2 DBREF 2ATY A 2 134 UNP P20023 CR2_HUMAN 21 153 DBREF 2ATY A 150 376 UNP P01868 IGHG1_MOUSE 98 324 DBREF 2ATY B 2 134 UNP P20023 CR2_HUMAN 21 153 DBREF 2ATY B 150 376 UNP P01868 IGHG1_MOUSE 98 324 SEQADV 2ATY ASP A 1 UNP P20023 EXPRESSION TAG SEQADV 2ATY GLY A 135 UNP P20023 LINKER SEQADV 2ATY SER A 136 UNP P20023 LINKER SEQADV 2ATY ILE A 137 UNP P20023 LINKER SEQADV 2ATY GLU A 138 UNP P20023 LINKER SEQADV 2ATY GLY A 139 UNP P20023 LINKER SEQADV 2ATY ARG A 140 UNP P20023 LINKER SEQADV 2ATY GLY A 141 UNP P20023 LINKER SEQADV 2ATY GLY A 142 UNP P20023 LINKER SEQADV 2ATY SER A 143 UNP P20023 LINKER SEQADV 2ATY GLU A 144 UNP P20023 LINKER SEQADV 2ATY LEU A 145 UNP P20023 LINKER SEQADV 2ATY ALA A 146 UNP P20023 LINKER SEQADV 2ATY ASP A 147 UNP P20023 LINKER SEQADV 2ATY PRO A 148 UNP P20023 LINKER SEQADV 2ATY GLU A 149 UNP P20023 LINKER SEQADV 2ATY LEU A 277 UNP P01868 VAL 225 CONFLICT SEQADV 2ATY GLU A 331 UNP P01868 GLY 279 CONFLICT SEQADV 2ATY ASP B 1 UNP P20023 EXPRESSION TAG SEQADV 2ATY GLY B 135 UNP P20023 LINKER SEQADV 2ATY SER B 136 UNP P20023 LINKER SEQADV 2ATY ILE B 137 UNP P20023 LINKER SEQADV 2ATY GLU B 138 UNP P20023 LINKER SEQADV 2ATY GLY B 139 UNP P20023 LINKER SEQADV 2ATY ARG B 140 UNP P20023 LINKER SEQADV 2ATY GLY B 141 UNP P20023 LINKER SEQADV 2ATY GLY B 142 UNP P20023 LINKER SEQADV 2ATY SER B 143 UNP P20023 LINKER SEQADV 2ATY GLU B 144 UNP P20023 LINKER SEQADV 2ATY LEU B 145 UNP P20023 LINKER SEQADV 2ATY ALA B 146 UNP P20023 LINKER SEQADV 2ATY ASP B 147 UNP P20023 LINKER SEQADV 2ATY PRO B 148 UNP P20023 LINKER SEQADV 2ATY GLU B 149 UNP P20023 LINKER SEQADV 2ATY LEU B 277 UNP P01868 VAL 225 CONFLICT SEQADV 2ATY GLU B 331 UNP P01868 GLY 279 CONFLICT SEQRES 1 A 376 ASP ILE SER CYS GLY SER PRO PRO PRO ILE LEU ASN GLY SEQRES 2 A 376 ARG ILE SER TYR TYR SER THR PRO ILE ALA VAL GLY THR SEQRES 3 A 376 VAL ILE ARG TYR SER CYS SER GLY THR PHE ARG LEU ILE SEQRES 4 A 376 GLY GLU LYS SER LEU LEU CYS ILE THR LYS ASP LYS VAL SEQRES 5 A 376 ASP GLY THR TRP ASP LYS PRO ALA PRO LYS CYS GLU TYR SEQRES 6 A 376 PHE ASN LYS TYR SER SER CYS PRO GLU PRO ILE VAL PRO SEQRES 7 A 376 GLY GLY TYR LYS ILE ARG GLY SER THR PRO TYR ARG HIS SEQRES 8 A 376 GLY ASP SER VAL THR PHE ALA CYS LYS THR ASN PHE SER SEQRES 9 A 376 MET ASN GLY ASN LYS SER VAL TRP CYS GLN ALA ASN ASN SEQRES 10 A 376 MET TRP GLY PRO THR ARG LEU PRO THR CYS VAL SER VAL SEQRES 11 A 376 PHE PRO LEU GLU GLY SER ILE GLU GLY ARG GLY GLY SER SEQRES 12 A 376 GLU LEU ALA ASP PRO GLU VAL PRO ARG ASP CYS GLY CYS SEQRES 13 A 376 LYS PRO CYS ILE CYS THR VAL PRO GLU VAL SER SER VAL SEQRES 14 A 376 PHE ILE PHE PRO PRO LYS PRO LYS ASP VAL LEU THR ILE SEQRES 15 A 376 THR LEU THR PRO LYS VAL THR CYS VAL VAL VAL ASP ILE SEQRES 16 A 376 SER LYS ASP ASP PRO GLU VAL GLN PHE SER TRP PHE VAL SEQRES 17 A 376 ASP ASP VAL GLU VAL HIS THR ALA GLN THR GLN PRO ARG SEQRES 18 A 376 GLU GLU GLN PHE ASN SER THR PHE ARG SER VAL SER GLU SEQRES 19 A 376 LEU PRO ILE MET HIS GLN ASP TRP LEU ASN GLY LYS GLU SEQRES 20 A 376 PHE LYS CYS ARG VAL ASN SER ALA ALA PHE PRO ALA PRO SEQRES 21 A 376 ILE GLU LYS THR ILE SER LYS THR LYS GLY ARG PRO LYS SEQRES 22 A 376 ALA PRO GLN LEU TYR THR ILE PRO PRO PRO LYS GLU GLN SEQRES 23 A 376 MET ALA LYS ASP LYS VAL SER LEU THR CYS MET ILE THR SEQRES 24 A 376 ASP PHE PHE PRO GLU ASP ILE THR VAL GLU TRP GLN TRP SEQRES 25 A 376 ASN GLY GLN PRO ALA GLU ASN TYR LYS ASN THR GLN PRO SEQRES 26 A 376 ILE MET ASN THR ASN GLU SER TYR PHE VAL TYR SER LYS SEQRES 27 A 376 LEU ASN VAL GLN LYS SER ASN TRP GLU ALA GLY ASN THR SEQRES 28 A 376 PHE THR CYS SER VAL LEU HIS GLU GLY LEU HIS ASN HIS SEQRES 29 A 376 HIS THR GLU LYS SER LEU SER HIS SER PRO GLY LYS SEQRES 1 B 376 ASP ILE SER CYS GLY SER PRO PRO PRO ILE LEU ASN GLY SEQRES 2 B 376 ARG ILE SER TYR TYR SER THR PRO ILE ALA VAL GLY THR SEQRES 3 B 376 VAL ILE ARG TYR SER CYS SER GLY THR PHE ARG LEU ILE SEQRES 4 B 376 GLY GLU LYS SER LEU LEU CYS ILE THR LYS ASP LYS VAL SEQRES 5 B 376 ASP GLY THR TRP ASP LYS PRO ALA PRO LYS CYS GLU TYR SEQRES 6 B 376 PHE ASN LYS TYR SER SER CYS PRO GLU PRO ILE VAL PRO SEQRES 7 B 376 GLY GLY TYR LYS ILE ARG GLY SER THR PRO TYR ARG HIS SEQRES 8 B 376 GLY ASP SER VAL THR PHE ALA CYS LYS THR ASN PHE SER SEQRES 9 B 376 MET ASN GLY ASN LYS SER VAL TRP CYS GLN ALA ASN ASN SEQRES 10 B 376 MET TRP GLY PRO THR ARG LEU PRO THR CYS VAL SER VAL SEQRES 11 B 376 PHE PRO LEU GLU GLY SER ILE GLU GLY ARG GLY GLY SER SEQRES 12 B 376 GLU LEU ALA ASP PRO GLU VAL PRO ARG ASP CYS GLY CYS SEQRES 13 B 376 LYS PRO CYS ILE CYS THR VAL PRO GLU VAL SER SER VAL SEQRES 14 B 376 PHE ILE PHE PRO PRO LYS PRO LYS ASP VAL LEU THR ILE SEQRES 15 B 376 THR LEU THR PRO LYS VAL THR CYS VAL VAL VAL ASP ILE SEQRES 16 B 376 SER LYS ASP ASP PRO GLU VAL GLN PHE SER TRP PHE VAL SEQRES 17 B 376 ASP ASP VAL GLU VAL HIS THR ALA GLN THR GLN PRO ARG SEQRES 18 B 376 GLU GLU GLN PHE ASN SER THR PHE ARG SER VAL SER GLU SEQRES 19 B 376 LEU PRO ILE MET HIS GLN ASP TRP LEU ASN GLY LYS GLU SEQRES 20 B 376 PHE LYS CYS ARG VAL ASN SER ALA ALA PHE PRO ALA PRO SEQRES 21 B 376 ILE GLU LYS THR ILE SER LYS THR LYS GLY ARG PRO LYS SEQRES 22 B 376 ALA PRO GLN LEU TYR THR ILE PRO PRO PRO LYS GLU GLN SEQRES 23 B 376 MET ALA LYS ASP LYS VAL SER LEU THR CYS MET ILE THR SEQRES 24 B 376 ASP PHE PHE PRO GLU ASP ILE THR VAL GLU TRP GLN TRP SEQRES 25 B 376 ASN GLY GLN PRO ALA GLU ASN TYR LYS ASN THR GLN PRO SEQRES 26 B 376 ILE MET ASN THR ASN GLU SER TYR PHE VAL TYR SER LYS SEQRES 27 B 376 LEU ASN VAL GLN LYS SER ASN TRP GLU ALA GLY ASN THR SEQRES 28 B 376 PHE THR CYS SER VAL LEU HIS GLU GLY LEU HIS ASN HIS SEQRES 29 B 376 HIS THR GLU LYS SER LEU SER HIS SER PRO GLY LYS CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000